Document Detail

Pharmacogenetic tests: the need for a level playing field.
MedLine Citation:
PMID:  23274456     Owner:  NLM     Status:  MEDLINE    
The delivery of more personalized medicinecould be accelerated by addressing the substantial differences in the level of evidence required for the inclusion of pharmacogenetic tests in treatment guidelines, drug labelling and reimbursement schemes compared with that needed for non-genetic diagnostic tests.
Munir Pirmohamed; Dyfrig A Hughes
Related Documents :
14127386 - Specificity of the isoniazid drop test for control of domiciliary treatment of tubercul...
15610806 - Diagnosis of tuberculosis in south african children with a t-cell-based assay: a prospe...
24798596 - Evaluation of diagnostic criteria for endemic nephropathy.
24882826 - Cardiac diagnostic testing: what bedside nurses need to know.
20174506 - Brain death diagnosis and apnea test safety.
24427956 - Homologous canavalia lectins elicit different patterns of antinociceptive responses.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Nature reviews. Drug discovery     Volume:  12     ISSN:  1474-1784     ISO Abbreviation:  Nat Rev Drug Discov     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2012-12-31     Completed Date:  2013-07-08     Revised Date:  2014-02-20    
Medline Journal Info:
Nlm Unique ID:  101124171     Medline TA:  Nat Rev Drug Discov     Country:  England    
Other Details:
Languages:  eng     Pagination:  3-4     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Drug Design
Drug Labeling
Genetic Testing / methods*
Individualized Medicine / methods*
Practice Guidelines as Topic
Reimbursement Mechanisms
Grant Support
G0800792//Medical Research Council

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Ro 32-0432 attenuates mecamylamine-precipitated nicotine withdrawal syndrome in mice.
Next Document:  Objective assessment of cancer genes for drug discovery.